StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note released on Monday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Up 25.0 %
Shares of Global Cord Blood stock opened at $1.50 on Monday. The firm has a market capitalization of $182.33 million, a P/E ratio of 2.34 and a beta of 0.16. Global Cord Blood has a 52 week low of $2.03 and a 52 week high of $5.50. The company has a 50 day moving average price of $1.35 and a 200 day moving average price of $1.38.
About Global Cord Blood
Read More
- Five stocks we like better than Global Cord Blood
- Do ETFs Pay Dividends? What You Need to Know
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- The Most Important Warren Buffett Stock for Investors: His Own
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- What is Insider Trading? What You Can Learn from Insider Trading
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.